About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Treating Psoriasis With Biologic Drugs Reduces Heart Disease Risk

by Mohamed Fathima S on February 5, 2019 at 4:40 PM
Treating Psoriasis With Biologic Drugs Reduces Heart Disease Risk

Treating a chronic inflammatory skin condition known as psoriasis with biologic drugs that target immune system activity could reduce the early plaque buildup in the arteries that leads to restricted blood flow and heart attacks, reveals a study in the journal Cardiovascular Research. Immunotherapies could thus be used to treat inflammatory conditions and reduce heart-related health risks.

"Classically a heart attack is caused by one of five risk factors: diabetes, hypertension, high cholesterol, family history, or smoking," said Nehal N. Mehta, M.D., head of the Lab of Inflammation and Cardiometabolic Diseases at NHLBI. "Our study presents evidence that there is a sixth factor, inflammation; and that it is critical to both the development and the progression of atherosclerosis to heart attack."

Advertisement


Now researchers provided first in-human evidence that treatment of a known inflammatory condition with biologic therapy, a type of drugs that suppresses the immune system, was associated with a reduction in coronary artery disease, in particular of rupture prone plaque which often leads to a heart attack.

Psoriasis, a common skin disease affecting 3-5 percent of the U.S. population, is associated with heightened systemic inflammation, which elevates risk of blood vessel disease and diabetes. Inflammation occurs when the body's defensive mechanism kicks in to ward off infection or disease, but this mechanism can turn against itself when triggered, for instance, by excess low-density lipoproteins (LDLs) that seep into the lining of the arteries.
Advertisement

The resulting inflammatory response can cause blood clots, which block arteries and can lead to heart attack and stroke. Inflammation puts 20-30 percent of the U.S. population at risk for these kinds of events. People with inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, and psoriasis have a much higher rate of cardiovascular events.

Those high rates make worse already troubling numbers: More than 15 million Americans, and many more worldwide, suffer from atherosclerotic cardiovascular disease. Heart attack occurs in 750,000 individuals every year in the United States; globally, more than 7 million people had heart attacks in 2015.

The current findings came from an observational study of the NIH Psoriasis Atherosclerosis Cardiometabolic Initiative cohort, which had 290 psoriasis patients, 121 of whom suffered moderate to severe skin disease and qualified for the biologic therapy approved by the U.S. Food and Drug Administration.

For a year, researchers followed the eligible patients, all of whom had low cardiovascular risk, and compared them to those who elected not to receive biologic therapy. Study results show that biologic therapy was associated with an 8 percent reduction in coronary artery plaque.

"The findings that intrigued us most were that coronary plaque sub-components changed over one year, including the necrotic core and non-calcified components, which are the culprits for most heart attacks," Mehta said.

Prior research had linked psoriasis with premature development of high-risk coronary plaque. Now, Mehta's team has shown beneficial changes in this plaque when psoriasis is treated with biologic therapy - even without changes in other cardiovascular risk factors such as cholesterol, glucose, and blood pressure.

"This appears to be an anti-inflammatory effect. In the absence of improvement in other cardiovascular risk factors, and without adding new cholesterol medications, patients' soft-plaque still improved. The only change was the severity of their skin disease," said Mehta.

Researchers say continued research will need to be done to confirm whether this is so, or whether the positive effect is a result of treating the underlying inflammatory disease.

"Our data are observational so the next steps should be randomized, controlled trials," concluded Mehta.



Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Heart Disease News

Link Between Obesity and Elevated Bad Cholesterol Heightens Heart Disease Threat
The inflammation associated with obesity worsens the impairment of 'bad cholesterol,' increasing the chances of experiencing heart disease conditions.
Does Climbing Five Stair Flights Daily Cut Heart Disease Risk?
Daily stair climbing particularly lowered the risk of cardiovascular disease in individuals with lower susceptibility.
Link Between Cannabis Use Disorder and Heart Problem Risk
The research adds to the ongoing discussion concerning the health consequences of cannabis use disorder and its possible associations with heart disease
Why Heart Attacks Surge Among School-Aged Children?
Dietary choices and a sedentary lifestyle are major factors in the rise of heart attacks among school-aged children.
1,250 New Heart Attacks in People Under 35 Reported in Bangalore in 2 Years
In the past two years, the Bangalore PCAD registry reported over 2,500 heart attack cases in individuals under 40, with 1,250 of them under 35.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Treating Psoriasis With Biologic Drugs Reduces Heart Disease Risk Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests